KMT2A and acute lymphoblastic leukemia: Likewise, cytogenetic abnormalities characteristic of B-ALL largely determine the biology of the disease, affect prognosis, and guide therapy.7 Presence of Ph+ BCR-ABL and MLL rearrangement are considered to have poor outcome.